52 research outputs found
Influence of Intraoperative Hemodynamic Parameters on Outcome in Simultaneous PancreasâKidney Transplant Recipient
Objectives: Adequate organ perfusion, as well as appropriate blood pressure levels at the time of unclamping, is crucial for early and long-term graft function and outcome in simultaneous pancreasâkidney transplantation (SPKT). However, the optimal intraoperative mean arterial pressure (MAP) level has not well been defined. Methods: From a prospectively collected database, the medical data of 105 patients undergoing SPKT at our center were retrospectively analyzed. A receiver operating characteristic (ROC) analysis was preliminarily performed for optimal cut-off value for MAP at reperfusion, to predict early pancreatic graft function. Due to these results, we divided the patients according to their MAP values at reperfusion into 91 mmHg (n = 58 patients) groups. Clinicopathological characteristics and outcomes, as well as early graft function and long-term survival, were retrospectively analyzed. Results: Donor and recipient characteristics were comparable between both groups. Rates of postoperative complications were significantly higher in the 91 mmHg group (vascular thrombosis of the pancreas: 7 (14%) versus 2 (3%); p = 0.03; pancreatitis/intraabdominal abscess: 10 (21%) versus 4 (7%); p = 0.03; renal delayed graft function (DGF): 11 (23%) versus 5 (9%); p = 0.03; postreperfusion urine output: 106 ± 50 mL versus 195 ± 45 mL; p = 0.04). There were no significant differences in intraoperative volume repletion, central venous pressure (CVP), use of vasoactive inotropic agents, and the metabolic outcome. Five-year pancreas graft survival was significantly higher in the >91 mmHg group (>91 mmHg: 82% versus 91 mmHg at the time point of reperfusion was associated with a reduced rate of postoperative complications, enhancing and recovering long-term graft function and outcome and thus increasing long-term survival in SPKT recipients
Predictive Value of HAS-BLED Score Regarding Bleeding Events and Graft Survival following Renal Transplantation
Objective: Due to the high prevalence and incidence of cardio- and cerebrovascular diseases
among dialysis-dependent patients with end-stage renal disease (ERSD) scheduled for kidney
transplantation (KT), the use of antiplatelet therapy (APT) and/or anticoagulant drugs in this patient
population is common. However, these patients share a high risk of complications, either due to
thromboembolic or bleeding events, which makes adequate peri- and post-transplant anticoagulation
management challenging. Predictive clinical models, such as the HAS-BLED score developed for
predicting major bleeding events in patients under anticoagulation therapy, could be helpful tools for
the optimization of antithrombotic management and could reduce peri- and postoperative morbidity
and mortality. Methods: Data from 204 patients undergoing kidney transplantation (KT) between
2011 and 2018 at the University Hospital Leipzig were retrospectively analyzed. Patients were
stratified and categorized postoperatively into the prophylaxis group (group A)âpatients without
pretransplant anticoagulation/antiplatelet therapy and receiving postoperative heparin in prophylactic
dosesâand into the (sub)therapeutic group (group B)âpatients with postoperative continued
use of pretransplant antithrombotic medication used (sub)therapeutically. The primary outcome
was the incidence of postoperative bleeding events, which was evaluated for a possible association
with the use of antithrombotic therapy. Secondary analyses were conducted for the associations of
other potential risk factors, specifically the HAS-BLED score, with allograft outcome. Univariate and
multivariate logistic regression as well as a Cox proportional hazard model were used to identify risk
factors for long-term allograft function, outcome and survival. The calibration and prognostic accuracy
of the risk models were evaluated using the HosmerâLemshow test (HLT) and the area under
the receiver operating characteristic curve (AUC) model. Results: In total, 94 of 204 (47%) patients received
(sub)therapeutic antithrombotic therapy after transplantation and 108 (53%) patients received
prophylactic antithrombotic therapy. A total of 61 (29%) patients showed signs of postoperative
bleeding. The incidence (p < 0.01) and timepoint of bleeding (p < 0.01) varied significantly between
the different antithrombotic treatment groups. After applying multivariate analyses, pre-existing
cardiovascular disease (CVD) (OR 2.89 (95% CI: 1.02â8.21); p = 0.04), procedure-specific complications
(blood loss (OR 1.03 (95% CI: 1.0â1.05); p = 0.014), ClavienâDindo classification > grade II (OR 1.03
(95% CI: 1.0â1.05); p = 0.018)), HAS-BLED score (OR 1.49 (95% CI: 1.08â2.07); p = 0.018), vit K antagonists
(VKA) (OR 5.89 (95% CI: 1.10â31.28); p = 0.037), the combination of APT and therapeutic
heparin (OR 5.44 (95% CI: 1.33â22.31); p = 0.018) as well as postoperative therapeutic heparin (OR 3.37
(95% CI: 1.37â8.26); p < 0.01) were independently associated with an increased risk for bleeding. The
intraoperative use of heparin, prior antiplatelet therapy and APT in combination with prophylactic heparin was not associated with increased bleeding risk. Higher recipient body mass index (BMI)
(OR 0.32 per 10 kg/m2 increase in BMI (95% CI: 0.12â0.91); p = 0.023) as well as living donor KT
(OR 0.43 (95% CI: 0.18â0.94); p = 0.036) were associated with a decreased risk for bleeding. Regarding
bleeding events and graft failure, the HAS-BLED risk model demonstrated good calibration (bleeding
and graft failure: HLT: chi-square: 4.572, p = 0.802, versus chi-square: 6.52, p = 0.18, respectively) and
moderate predictive performance (bleeding AUC: 0.72 (0.63â0.79); graft failure: AUC: 0.7 (0.6â0.78)).
Conclusions: In our current study, we could demonstrate the HAS-BLED risk score as a helpful tool
with acceptable predictive accuracy regarding bleeding events and graft failure following KT. The
intensified monitoring and precise stratification/assessment of bleeding risk factors may be helpful
in identifying patients at higher risks of bleeding, improved individualized anticoagulation decisions
and choices of antithrombotic therapy in order to optimize outcome after kidney transplantatio
Correlation of Different Serum Biomarkers with Prediction of Early Pancreatic Graft Dysfunction Following Simultaneous Pancreas and Kidney Transplantation
Background: Despite recent advances and refinements in perioperative management of simultaneous pancreasâkidney transplantation (SPKT) early pancreatic graft dysfunction (ePGD) remains a critical problem with serious impairment of early and long-term graft function and outcome. Hence, we evaluated a panel of classical blood serum markers for their value in predicting early graft dysfunction in patients undergoing SPKT. Methods: From a prospectively collected database medical data of 105 patients undergoing SPKT between 1998 and 2018 at our center were retrospectively analyzed. The primary study outcome was the detection of occurrence of early pancreatic graft dysfunction (ePGD), the secondary study outcome was early renal graft dysfunction (eRGD) as well as all other outcome parameters associated with the graft function. In this context, ePGD was defined as pancreas graft-related complications including graft pancreatitis, pancreatic abscess/peritonitis, delayed graft function, graft thrombosis, bleeding, rejection and the consecutive need for re-laparotomy due to graft-related complications within 3 months. With regard to analyzing ePGD, serum levels of white blood cell count (WBC), C-reactive protein (CRP), procalcitonin (PCT), pancreatic lipase as well as neutrophilâlymphocyte ratio (NLR) and plateletâlymphocyte ratio (PLR) were measured preoperatively and at postoperative days (POD) 1, 2, 3 and 5. Further, peak serum levels of CRP and lipase during the first 72 h were evaluated. Receiver operating characteristics (ROC) curves were performed to assess their predictive value for ePGD and eRGD. Cut-off levels were calculated with the Youden index. Significant diagnostic biochemical cut-offs as well as other prognostic clinical factors were tested in a multivariate logistic regression model. Results: Of the 105 patients included, 43 patients (41%) and 28 patients (27%) developed ePGD and eRGD following SPKT, respectively. The mean WBC, PCT, NLR, PLR, CRP and lipase levels were significantly higher on most PODs in the ePGD group compared to the non-ePGD group. ROC analysis indicated that peak lipase (AUC: 0.82) and peak CRP levels (AUC: 0.89) were highly predictive for ePGD after SPKT. The combination of both achieved the highest AUC (0.92; p 150 IU/L (OR 2.9 (95% CI: 1.2â7.13), p = 0.021) and CRP levels of â„ 180 ng/mL on POD 2 (OR 3.6 (95% CI: 1.54â8.34), p 150 ng/mL on POD 3 (OR 4.5 (95% CI: 1.7â11.4), p < 0.01) were revealed as independent biochemical predictive variables for ePGD after transplantation. Conclusions: In the current study, the combination of peak lipase and CRP levels were highly effective in predicting early pancreatic graft dysfunction development following SPKT. In contrast, for early renal graft dysfunction the predictive value of this parameter was less sensitive. Intensified monitoring of these parameters may be helpful for identifying patients at a higher risk of pancreatic ischemia reperfusion injury and various IRI- associated postoperative complications leading to ePGD and thus deteriorated outcome
Physical activity is related to disease severity and fatigue, but not to relapse rate in persons with relapsing remitting multiple sclerosis â a self-reported questionnaire based study
IntroductionBased on theoretical models, physical activity has been introduced as a promoting method to mitigate the disease severity, fatigue and relapse rate in multiple sclerosis. The primary objective of the study was to investigate the relation between self-reported physical activity level and disease severity, fatigue and relapse rate in persons with relapsing remitting multiple sclerosis (RRMS).MethodsA survey was offered to persons with RRMS from March 2019 to August 2021 (nâ=â253). Physical activity level, fatigue and disease severity were determined using the Godin Leisure-Time Questionnaire (GLTEQ), the Patient Determined Disease Steps (PDDS) scale and the Fatigue Scale for Motor and Cognitive Functions (FSMC). Additionally, participantsâ relapse rate was recorded.ResultsBivariate correlations revealed an inverse relation between physical activity level and PDDS (Ïâ=ââ0.279; pâ<â0.001) as well as between physical activity and FSMC (râ=ââ0.213, pâ<â0.001), but not between physical activity and relapse rate (râ=â0.033, pâ>â0.05). Multiple linear regression analyses explained 12.6% and 5.2% of the variance of PDDS and FSMC.ConclusionOur findings confirm a relation between self-reported physical activity, disease severity and fatigue in persons with RRMS. However, self-reported physical activity level does not seem to affect the annualised relapse rate
Locating functionalized gold nanoparticles using electrical impedance tomography
Objective: An imaging device to locate functionalised nanoparticles, whereby therapeutic agents are transported from the site of administration specifically to diseased tissues, remains a challenge for pharmaceutical research. Here, we show a new method based on electrical impedance tomography (EIT) to provide images of the location of gold nanoparticles (GNPs) and the excitation of GNPs with radio frequencies (RF) to change impedance permitting an estimation of their location in cell models
Methods: We have created an imaging system using quantum cluster GNPs as contrast agent, activated with RF fields to heat the functionalized GNPs, which causes a change in impedance in the surrounding region. This change is then identified with EIT.
Results: Images of impedance changes of around 80±4% are obtained for a sample of citrate stabilized GNPs in a solution of phosphate-buffered saline. A second quantification was carried out using colorectal cancer cells incubated with culture media, and the internalization of GNPs into the colorectal cancer cells was undertaken to compare them with the EIT images. When the cells were incubated with functionalised GNPs, the change was more apparent, approximately 40±2%. This change was reflected in the EIT image as the cell area was more clearly identifiable from the rest of the area.
Significance: EIT can be used as a new method to locate functionalized GNPs in human cells and help in the development of GNP-based drugs in humans to improve their efficacy in the future
Resorbable screws versus pins for optimal transplant fixation (SPOT) in anterior cruciate ligament replacement with autologous hamstring grafts: rationale and design of a randomized, controlled, patient and investigator blinded trial [ISRCTN17384369]
BACKGROUND: Ruptures of the anterior cruciate ligament (ACL) are common injuries to the knee joint. Arthroscopic ACL replacement by autologous tendon grafts has established itself as a standard of care. Data from both experimental and observational studies suggest that surgical reconstruction does not fully restore knee stability. Persisting anterior laxity may lead to recurrent episodes of giving-way and cartilage damage. This might at least in part depend on the method of graft fixation in the bony tunnels. Whereas resorbable screws are easy to handle, pins may better preserve graft tension. The objective of this study is to determine whether pinning of ACL grafts reduces residual anterior laxity six months after surgery as compared to screw fixation. DESIGN/ METHODS: SPOT is a randomised, controlled, patient and investigator blinded trial conducted at a single academic institution. Eligible patients are scheduled to arthroscopic ACL repair with triple-stranded hamstring grafts, conducted by a single, experienced surgeon. Intraoperatively, subjects willing to engage in this study will be randomised to transplant tethering with either resorbable screws or resorbable pins. No other changes apply to locally established treatment protocols. Patients and clinical investigators will remain blinded to the assigned fixation method until the six-month follow-up examination. The primary outcome is the side-to-side (repaired to healthy knee) difference in anterior translation as measured by the KT-1000 arthrometer at a defined load (89 N) six months after surgery. A sample size of 54 patients will yield a power of 80% to detect a difference of 1.0 mm ± standard deviation 1.2 mm at a two-sided alpha of 5% with a t-test for independent samples. Secondary outcomes (generic and disease-specific measures of quality of life, magnetic resonance imaging morphology of transplants and devices) will be handled in an exploratory fashion. CONCLUSION: SPOT aims at showing a reduction in anterior knee laxity after fixing ACL grafts by pins compared to screws
Verteiltes Gassensornetzwerk fĂŒr die ortsaufgelöste Messung von Gasen im Katastrophenumfeld
In der vorliegenden Arbeit wird ein Sensornetzwerk mit Sensorknoten zur ortsaufgelösten Messung von gefĂ€hrlichen Gasen und die Rekonstruktion der Gasverteilung in einem Katastrophenumfeld vorgestellt. Nach der Verteilung der Sensorknoten im Katastrophengebiet, z.B. mit Robotern, arbeiten die Sensorknoten autark. Zum Erstellen einer Schadstoffkarte mit der Ausbreitung gefĂ€hrlicher Gase mĂŒssen drei Verarbeitungsschritte durchgefĂŒhrt werden: Die Detektion der Gase mit Sensoren, die Lokalisierung der Sensorknoten und die Sensordatenfusion zur Rekonstruktion der vorliegenden Gasausbreitung im Raum. Das Ziel ist eine vollstĂ€ndige Dezentralisierung der Datenerfassung und Datenauswertung mit einem drahtlosen Sensornetz. Das hier vorgestellte System ist ein Sensorknoten, mit dem verschiedene Gase, Temperatur und die relative Luftfeuchte erfasst werden. Dabei werden besonders kostengĂŒnstige und energiearme Messmethoden verwendet. Zur Detektion der Gase werden zwei verschiedene Sensortypen eingesetzt, ein Metalloxidgassensor und ein kolorimetrischer Sensor. Durch intelligente Fusion der Sensordaten mit einem kĂŒnstlichen neuronalen Netzwerk wird der selektive Nachweis einzelner Gase erreicht. Das System verwendet Ultraschallsensoren und Ultraschallemitter zur relativen Lokalisierung der Sensorknoten in InnenrĂ€umen. Die entwickelte Methode zur Rekonstruktion der vorliegenden Situation liefert eine Ăbersicht ĂŒber die Verteilung der Gase. Ăber ZigBee erfolgt die Kommunikation der Sensorknoten untereinander und mit ihrer Umwelt
- âŠ